US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

Federal Trade Commission News

US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Prescription DrugsNovo NordiskBlockbuster Drugs
  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 32 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 47%
  • Publisher: 63%

WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest...

WASHINGTON — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting

“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs, forcing Americans to pay sky-high prices for medicines they rely on,” said FTC Chair Lina Khan, in a statement.Ozempic is part of a class of drugs that were originally developed to treat diabetes but which have recently been approved to treat obesity, generating a surge in prescribing. Medicare spending on the drugs has also spiked in recent years.

'Nasty' norovirus on the rise in Canada: Symptoms to know and how to stay safe as contagious virus spreads at 'higher frequency'

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooFinanceCA /  🏆 47. in CA

Prescription Drugs Novo Nordisk Blockbuster Drugs Patents Federal Regulators Generic Medicines President Joe Biden Generic Drugmakers Astrazeneca

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic ‘Oops’ Babies Spark Debate About Weight-Loss Shot Use as Fertility DrugsOzempic ‘Oops’ Babies Spark Debate About Weight-Loss Shot Use as Fertility DrugsA surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant. That’s leading to questions about the safety of medications from Novo Nordisk A/S and Eli Lilly & Co. during pregnancy.
Read more »

U.S. Senate committee investigates pricing of Novo’s Ozempic and WegovyU.S. Senate committee investigates pricing of Novo’s Ozempic and WegovySenator Bernie Sanders sent a letter to Novo’s CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries
Read more »

US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »

US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »

TikTok’s Crackdown on Ozempic Influencers Threatens Weight-Loss Drug Hype MachineTikTok’s Crackdown on Ozempic Influencers Threatens Weight-Loss Drug Hype MachineCreators say the rules are unfair and harmful to their businesses
Read more »

No link between Ozempic, Wegovy and suicide, EU drug regulators sayNo link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal ...
Read more »



Render Time: 2025-02-19 21:47:23